Anne Bruinvels, PhD

Anne Bruinvels is a highly accomplished professional with a background in personalized healthcare, research and development, and personalized medicine. She is renowned for her expertise in companion diagnostics and therapeutics for central nervous system disorders. Anne is the founder of Px HealthCare, a data analytics venture focusing on developing mobile health apps to provide cancer patients with support and insights. With the creation of 'OWise breast cancer' app, Px aims to enhance cancer treatment outcomes through real-time patient reported data. Anne's exceptional track record includes serving as the Executive Director of the European Personalised Medicine Association (EPEMED) and founding Curidium, a personalized medicine company that went public on the AIM of the London Stock Exchange. Her impressive career also includes roles at Pharmagene, SmithKline Beecham, and Wyeth, contributing significantly to the growth of these organizations. Anne's academic journey includes a PhD in Neuroscience from the University of Utrecht and an MSc in Pharmacy from the University of Groningen. She was awarded the London Biotechnology Network's 'Young Entrepreneur of the Year Award' in 2003. Anne currently holds the position of NHS Innovation Fellow, showcasing her commitment to driving innovation in healthcare.